Ignite Creation Date:
2025-12-25 @ 5:03 AM
Ignite Modification Date:
2026-01-15 @ 3:00 PM
Study NCT ID:
NCT05493618
Status:
WITHDRAWN
Last Update Posted:
2023-01-27
First Post:
2022-08-05
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Pembrolizumab, Belantamab and Dexamethasone in Refractory Multiple Myeloma.
Sponsor:
Organization: